Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Annals of Surgical Oncology|May 24, 2015
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric AdenocarcinomaChristoph Springfeld, Christiane Wiecha, Romy Kunzmann, et al.
Cancers|March 10, 2022
STAT1 and STAT3 Exhibit a Crosstalk and Are Associated with Increased Inflammation in Hepatocellular CarcinomaCarolin Ploeger, Johannes Schreck, Thorben Huth, et al.
BMC Cancer|January 17, 2019
Programmed cell death ligand 1 (PD-L1, CD274) in cholangiocarcinoma - correlation with clinicopathological data and comparison of antibodiesMark Kriegsmann, Stephanie Roessler, Katharina Kriegsmann, et al.
JHEP Reports : Innovation in Hepatology|April 15, 2024
A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinomaArmando Santoro, Eric Assenat, Thomas Yau, et al.
The British Journal of Surgery|April 28, 2022
Repeat liver resection for recurrent intrahepatic cholangiocarcinoma: meta-analysisAli Ramouz, Sadeq Ali-Hasan-Al-Saegh, Saeed Shafiei, et al.
Molecular Therapy Oncolytics|July 11, 2018
Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target SitesMathias Felix Leber, Marc-Andrea Baertsch, Sophie Caroline Anker, et al.
BMC Cancer|January 22, 2022
Statin use is associated with the reduction in hepatocellular carcinoma recurrence after liver surgeryElias Khajeh, Arash Dooghaie Moghadam, Pegah Eslami, et al.
Cold Spring Harbor Molecular Case Studies|August 27, 2020
Successful BRAF/MEK inhibition in a patient with BRAFV600E-mutated extrapancreatic acinar cell carcinomaElena Busch, Simon Kreutzfeldt, Abbas Agaimy, et al.
Radiation Oncology (London, England)|February 19, 2025
Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancerPaula Hoffmeister-Wittmann, Philipp Hoegen-Saßmannshausen, Livia Wicklein, et al.
Targeted Oncology|February 28, 2024
Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World DataAlexander Olkus, Aurelie Tomczak, Anne Katrin Berger, et al.
Pageof 13